Jaroslaw Kierkus
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.
Journal: Journal of Crohn's & colitis
Published: March 17, 2026
Sexual Functioning of Patients with Inflammatory Bowel Disease.
Journal: Journal of clinical medicine
Published: February 02, 2026
Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: December 18, 2025
Tasty&Healthy Whole-Food Diet in Asymptomatic Children and Young Adults With Biologically Active Crohn's Disease: The TASTI-E Randomized Controlled Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 17, 2025
Multi-omics-based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy.
Journal: Inflammatory bowel diseases
Published: August 28, 2025
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN.
Journal: Gastroenterology
Published: August 13, 2025
Once-daily oral ritlecitinib or brepocitinib versus placebo in patients with moderate-to-severely active Crohn's disease (PIZZICATO): an international, randomised, phase 2a trial.
Journal: EClinicalMedicine
Published: June 30, 2025
Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.
Journal: Inflammatory bowel diseases
Published: June 25, 2025
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).
Journal: Journal of Crohn's & colitis
Published: April 17, 2025
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial.
Journal: Gastroenterology
Published: February 26, 2025
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 25, 2025
Last Updated: 09/26/2026